Moreover, we studied the potential impacts of CYP3A4 and CYP3A5 genotypes on post-kidney transplant complications such as delayed graft function, rejection, BK infections, viral acute graft pyelonephritis, and suspected calcineurin inhibitor nephrotoxicity. Here, CYP3A4 is linked to urogenital neoplasm.